Acquired Resistance to KRAS G12C Inhibitor trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Acquired Resistance to KRAS G12C Inhibitor trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
  NCT05786924 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.